Phathom Pharmaceuticals (PHAT) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$0.41.
- Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) rose 6893.94% to -$0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.77, marking a year-over-year increase of 3443.48%. This contributed to the annual value of -$5.29 for FY2024, which is 3476.07% down from last year.
- Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$0.41 in Q3 2025, which was up 6893.94% from -$1.05 recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of -$0.41 during Q3 2025, and its lowest value of -$1.56 during Q2 2024.
- Over the past 4 years, Phathom Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$1.31 (recorded in 2025), while the average stood at -$1.16.
- In the last 5 years, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 8571.43% in 2024 and then surged by 6893.94% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.4 in 2022, then decreased by 10.41% to -$1.55 in 2023, then rose by 23.98% to -$1.18 in 2024, then skyrocketed by 65.23% to -$0.41 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.41 in Q3 2025, compared to -$1.05 in Q2 2025 and -$1.31 in Q1 2025.